Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
541 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Condition: Resectable Pancreatic Cancers
Interventions: Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Other: Sugical resection;   Drug: Adjuvant chemotheapy
22 Recruiting Pancreatic Cancer Genetics
Condition: Pancreatic Cancer
Intervention:
23 Recruiting Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer Non-resectable
Interventions: Drug: Folfirinox;   Radiation: Stereotactic Body Radiation Therapy
24 Recruiting Sequential Treatment Nab-paclitaxel + Gemcitabine / FOLFIRI.3 vs Nab-paclitaxel + Gemcitabine in 1st Line of Treatment of Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: FOLFIRI.3;   Drug: nab-paclitaxel+ gemcitabine
25 Recruiting Onco-geriatric Database of Patients With Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection
26 Recruiting Gemcitabine Plus BPM31510 Administered Intravenously in Advanced Pancreatic Cancer Patients
Condition: Pancreatic Cancer
Interventions: Drug: BPM31510 Nanosuspension Injection;   Drug: Gemcitabine
27 Recruiting Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Dietary Supplement: T-ChOS;   Drug: Gemcitabine;   Dietary Supplement: Placebo;   Drug: Capecitabine
28 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
29 Recruiting Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Radiation: 24 Gy in 3 fractions
30 Recruiting IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Radiation: Concurrent chemoradiotherapy(CCRT);   Radiation: Stereotactic Radiotherapy(SBRT);   Drug: S-1
31 Recruiting First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 en Entretien Versus Firgem
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: LV5FU2;   Drug: FOLFIRI;   Drug: Gemzar
32 Recruiting Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: NK cells;   Procedure: irreversible electroporation (IRE )
33 Recruiting Tumor Registry Pancreatic Cancer
Condition: Pancreas Cancer
Intervention:
34 Recruiting Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: Theragene®,Ad5-yCD/mutTKSR39rep-ADP
35 Recruiting Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours
Condition: Pancreatic Cancer
Intervention: Drug: Oxaliplatin, irinotecan, 5-FU & leucovorin
36 Recruiting Quality of Life Study in Patients With Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine in Combination With Nab-paclitaxel
Condition: Pancreatic Cancer
Interventions: Drug: Abraxane (nab-paclitaxel);   Drug: Gemcitabine
37 Recruiting Exercise Intervention Study for Pancreatic Cancer Patients
Condition: Pancreatic Cancer
Interventions: Behavioral: Six months supervised resistance training;   Behavioral: Six months home-based exercise training
38 Recruiting The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
Condition: Pancreatic Cancer
Interventions: Drug: Gadobutrol;   Drug: [F-18]HX4;   Drug: Gemcitabine;   Radiation: Radiotherapy;   Procedure: Pancreaticoduodenectomy
39 Recruiting Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
Condition: Pancreatic Cancer
Intervention: Drug: Gadobutrol
40 Recruiting Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: gemcitabine and nab paclitaxel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.